Advice
Withdrawn
tegafur/gimeracil/oteracil (Teysuno) is no longer available in the UK for the treatment of advanced gastric cancer when given in combination with cisplatin.
Medicine details
- Medicine name:
- tegafur/gimeracil/oteracil (Teysuno)
- SMC ID:
- 802/12
- Indication:
For the treatment of advanced gastric cancer when given in combination with cisplatin.
- Pharmaceutical company
- Nordic Pharma UK
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Full
- Status
- Withdrawn
- Date advice published
- 10 September 2012
Additional notes
tegafur/gimeracil/oteracil (Teysuno) is no longer available in the UK for the treatment of advanced gastric cancer when given in combination with cisplatin.